NCT05235945 The Effect of Exercise in Patients Awaiting Bariatric Surgery
| NCT ID | NCT05235945 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University College, London |
| Condition | Bariatric Surgery Candidate |
| Study Type | INTERVENTIONAL |
| Enrollment | 48 participants |
| Start Date | 2023-06-16 |
| Primary Completion | 2025-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 48 participants in total. It began in 2023-06-16 with a primary completion date of 2025-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this project is to understand the impact of a four week preoperative exercise programme on fitness and metabolic rate and weight before surgery. A multi-site randomised trial sponsored by UCL, recruiting patients awaiting bariatric surgery for obesity at University College London Hospital (UCLH), Whittington Health NHS Trust, or Homerton University Hospital NHS Foundation Trust. The investigators will measure fitness, metabolic rate, body weight/composition and grip strength in all participants, before and after a four-week supervised physical activity intervention. The investigators will also interview participants about their participation in the study in regard to the planning of future studies.
Eligibility Criteria
Inclusion Criteria: 1. Adults, aged 18 and above. 2. Patients enrolled in the UCLH, Homerton or Whittington Hospitals bariatric surgery program with BMI \> 30 kg/m2 3. ≤5 % variation in body weight over preceding 3 months. 4. Willing and able to comply with the trial protocol. 5. Willing and able to provide written informed consent 6. Male or Female Exclusion Criteria: 1. Pregnant or lactating mothers. 2. Weight over 180 kg (due to weight restrictions of equipment used). 3. Current use of betablockade. 4. Concurrent participation in other clinical intervention trial. 5. Clinically significant medical co-morbidities (e.g. uncontrolled hypertension, unstable cardiovascular disease) that could place at risk of an adverse response to exercise. 6. History of atrial fibrillation, unstable angina, acute coronary syndrome, congestive heart failure New York Heart Association class III-IV within the preceding 12 months.
Contact & Investigator
Belinda Durey
PRINCIPAL INVESTIGATOR
UCL, UniSA and UNSW
Frequently Asked Questions
Who can join the NCT05235945 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Bariatric Surgery Candidate. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05235945 currently recruiting?
Yes, NCT05235945 is actively recruiting participants. Contact the research team at daniel.martin@plymouth.ac.uk for enrollment information.
Where is the NCT05235945 trial being conducted?
This trial is being conducted at London, United Kingdom.
Who is sponsoring the NCT05235945 clinical trial?
NCT05235945 is sponsored by University College, London. The principal investigator is Belinda Durey at UCL, UniSA and UNSW. The trial plans to enroll 48 participants.